Steve Persaud, MD, PhD

Assistant Professor @WashUMedicine | Antibody-based conditioning for stem cell transplant and its impact on host biology | #PhysicianScientist #NewPI #bmtsm

[Steve Persaud, MD, PhD @PersaudSquad]

While I have mixed feelings about being back on Twitter, I have nothing but pride for this paper, my first mentee @AdityaYelamali 's first first author paper and my first paper as senior author.

Glad to have found a good home for this study in Blood ICT @BloodPortfolio

[Blood Journals Portfolio @BloodPortfolio]

This article, recently published in Blood ICT, was accepted through our second look rapid response program. Check it out and consider giving your own research a second chance: https://t.co/0l0CbHudtc

[Steve Persaud, MD, PhD @PersaudSquad]

Proud to amplify this study from Seung Kim’s lab about using antibody conditioning and JAK inhibition for allo-HSCT/tolerance induction for islet transplantation to treat NOD diabetes. Also grateful to have been able to write a short article about it with @Dipersiolab

[Journal of Clinical Investigation @jclinicalinvest]

Preventing graft re-JAK-tion: safer transplant conditioning enables murine islet allograft tolerance and #diabetes reversal: https://t.co/bGO42t2iHA

Stephen P. Persaud @PersaudSquad & John F. DiPersio @DiPersioLab @washumedicine provide a Commentary on Preksha Bhagchandani et al.: https://t.co/eI6GnQ0ajo

[Journal of Clinical Investigation @jclinicalinvest]

Curing autoimmune diabetes in mice!

Preksha Bhagchandani @prekshab17 et al. @StanfordMed present a clinically translatable, low toxicity conditioning regimen in combination with hematopoietic cell and islet transplantation that reverses established type 1 diabetes in mice: https://t.co/pwtgyGKK7M

The image: Histology of the recovered islet graft in diabetic mice that received allogeneic hematopoietic cell and islet transplantation shows intact B6 islets with few CD45+ immune cells 20 weeks after transplantation.